The obtained data from genomic experiments were analyzed using dedicated software. Signal processing, mapping, and quality control were performed with Torrent Suite Software, v.5.2 (Life Technologies). The sequence variants were called, and data were analyzed using the Ion Reporter with the AmpliSeq CHPv2 single-sample workflow and default settings. The Variant Caller plugin included in the Torrent Suite Software (v.3.6; Thermo Fisher Scientific, Carlsbad, CA, USA) and the MutationTaster2 algorithm were used to identify variations in target regions. Variants were categorized according to whether they comprised a nonsynonymous or frameshift mutation or stop codon in the exonic region. Each of the identified genetic variations was coded according to “plus strand” of the Human Genome assembly hg19. The limit of detection was a 5% mutational allelic frequency at 250 × coverage depth for each tested region.
To analyze a putative function of mutations as driver mutations, we employed four separate programs: SIFT [42], Polyphen-2 [43], and MutationTaster2 [44], as well as FATHMM (functional analysis through hidden Markov models (v2.3), which resulted in an index, calculated with a high- throughput web-server, able to predict the functional consequences of both coding variants, i.e., non-synonymous single nucleotide variants (nsSNVs), and non-coding variants to distinguish between cancer-promoting/driver mutations and other germline polymorphisms [45].
We checked for the presence of particular mutations and their previous reports in the catalogue of somatic mutations in cancer (COSMIC), the dbSNP, 1000 Genome Project, ClinVar, and ExAC databases.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.